Literature DB >> 12091430

The role of Src family kinases in cortical cataract formation.

Jian Zhou1, A Sue Menko.   

Abstract

PURPOSE: The goal of this study was to determine the role of Src family kinases (SFKs) in the development of lens cataract. This question was particularly significant, because these tyrosine kinases mediate the stress pathways known to lead to cataract formation. The experiments were focused on whether the inhibition of SFK activity suppresses the formation of lens opacities.
METHODS: A whole-lens culture system was developed, in which cortical opacities formed within 5 days, in embryonic day (E)10 lenses grown in medium containing 10% fetal bovine serum. SFK activity was blocked in the cultured lenses by growth in the presence of the SFK-specific inhibitor PP1. Control cultures were grown in medium without inhibitor or in the presence of PP3, the inactive analogue of PP1. Lenses were cultured for 10 days, observed, and photographed daily. Opacification was quantified with image-analysis software. Tissue architecture was determined after hematoxylin and eosin staining and cellular organization by fluorescent localization of filamentous actin with fluorescein-conjugated phalloidin.
RESULTS: Almost all lenses in the control cultures developed cortical opacities covering approximately 50% of the lens area by day 10. Similar to control cultures, PP1-treated lenses showed mild posterior opacities during the first 5 days in culture, but then became strikingly transparent. Only 7% of the PP1-treated lenses showed development of cortical cataract, and the average area of opacity was just 0.5% by culture day 10. In all cultured lenses, even in the presence of the PP1 inhibitor, the bow region of the lens extended to the posterior pole, and distribution of nuclei from the posterior pole toward the anterior aspects of the lens suggested that newly added fiber cells were misdirected. However, neither this feature, nor the presence of vacuoles appeared to correlate with the development of opacity in the cultured lenses. Instead, the lens opacities appeared to result from gross abnormalities in the shape and organization of cells in the equatorial and cortical fiber zones, as observed by F-actin staining. Culturing the lenses in the presence of the SFK inhibitor prevented these lens cell aberrations as well as the development of lens opacity.
CONCLUSIONS: The formation of cataract can involve activation of SFK-mediated pathway(s) leading to disorganization of developing lens fiber cells, and inhibiting these tyrosine kinases blocks cataract progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091430

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

1.  Short-term culturing of teleost crystalline lenses combined with high-resolution optical measurements.

Authors:  J Marcus Schartau; Ronald H H Kröger; Bodil Sjögreen
Journal:  Cytotechnology       Date:  2010-04-17       Impact factor: 2.058

2.  Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.

Authors:  Kun-Che Chang; Linfeng Li; Theresa M Sanborn; Biehuoy Shieh; Patricia Lenhart; David Ammar; Daniel V LaBarbera; J Mark Petrash
Journal:  J Nat Prod       Date:  2016-05-03       Impact factor: 4.050

3.  Regulation of transforming growth factor β-mediated epithelial-mesenchymal transition of lens epithelial cells by c-Src kinase under high glucose conditions.

Authors:  Zhi-Hua Han; Fang Wang; Fu-Lei Wang; Qi Liu; Jian Zhou
Journal:  Exp Ther Med       Date:  2018-06-22       Impact factor: 2.751

4.  Focal adhesion kinase (FAK) expression and activation during lens development.

Authors:  Maria I Kokkinos; Heidi J Brown; Robbert U de Iongh
Journal:  Mol Vis       Date:  2007-03-26       Impact factor: 2.367

5.  A Role for Calcium-Activated Adenylate Cyclase and Protein Kinase A in the Lens Src Family Kinase and Na,K-ATPase Response to Hyposmotic Stress.

Authors:  Mohammad Shahidullah; Amritlal Mandal; Nicholas A Delamere
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-09-01       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.